These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34055932)

  • 21. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
    Lu DY; Ventoulis I; Liu H; Kudchadkar SM; Greenland GV; Yalcin H; Kontari E; Goyal S; Corona-Villalobos CP; Vakrou S; Zimmerman SL; Abraham TP; Abraham MR
    Am Heart J; 2020 Jan; 219():58-69. PubMed ID: 31726421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
    Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictors of right ventricular function and size in patients with hypertrophic cardiomyopathy.
    Śpiewak M; Kłopotowski M; Mazurkiewicz Ł; Kowalik E; Petryka-Mazurkiewicz J; Miłosz-Wieczorek B; Klisiewicz A; Witkowski A; Marczak M
    Sci Rep; 2020 Dec; 10(1):21054. PubMed ID: 33273702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing right ventricular function in patients with hypertrophic cardiomyopathy with cardiac MRI: correlation with the New York Heart Function Assessment (NYHA) classification.
    Zhang S; Yang ZG; Sun JY; Wen LY; Xu HY; Zhang G; Guo YK
    PLoS One; 2014; 9(9):e104312. PubMed ID: 25180597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA; Schinkel AF; de Groot NM; van Domburg RT; Ten Cate FJ; Michels M
    Clin Cardiol; 2014 Aug; 37(8):493-8. PubMed ID: 25044226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy.
    Yang WI; Shim CY; Kim YJ; Kim SA; Rhee SJ; Choi EY; Choi D; Jang Y; Chung N; Cho SY; Ha JW
    J Am Soc Echocardiogr; 2009 Dec; 22(12):1338-43. PubMed ID: 19879733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Impact of Left Atrial Minimal Volume on Clinical Outcome in Patients with Non-Obstructive Hypertrophic Cardiomyopathy.
    Shin SH; Jang JH; Baek YS; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
    Int Heart J; 2018 Sep; 59(5):991-995. PubMed ID: 30158386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance of left atrial size in predicting adverse clinical events in hypertrophic cardiomyopathy].
    Kahveci G; Bayrak F; Mutlu B; Başaran Y
    Turk Kardiyol Dern Ars; 2008 Dec; 36(8):541-5. PubMed ID: 19223720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    Sorajja P; Pedersen WA; Bae R; Lesser JR; Jay D; Lin D; Harris K; Maron BJ
    J Am Coll Cardiol; 2016 Jun; 67(24):2811-8. PubMed ID: 27311518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E/e' ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction.
    Lu DY; Haileselassie B; Ventoulis I; Liu HY; Liang HY; Pozios I; Canepa M; Phillip S; Abraham MR; Abraham T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):101-107. PubMed ID: 28977350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).
    Guttmann OP; Pavlou M; O'Mahony C; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; Garcia-Pavia P; McKenna WJ; Omar RZ; Elliott PM;
    Eur J Heart Fail; 2015 Aug; 17(8):837-45. PubMed ID: 26183688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart Failure Progression in Hypertrophic Cardiomyopathy　- Possible Insights From Cardiopulmonary Exercise Testing.
    Magrì D; Re F; Limongelli G; Agostoni P; Zachara E; Correale M; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
    Circ J; 2016 Sep; 80(10):2204-11. PubMed ID: 27628102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy.
    Peteiro J; Bouzas-Mosquera A; Fernandez X; Monserrat L; Pazos P; Estevez-Loureiro R; Castro-Beiras A
    J Am Soc Echocardiogr; 2012 Feb; 25(2):182-9. PubMed ID: 22137254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Features of Heart Failure in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort　- Results From the Kochi RYOMA Study.
    Miyamoto Y; Kubo T; Ochi Y; Baba Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    Circ J; 2022 Nov; 86(12):1934-1940. PubMed ID: 35675987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model Embraced Electromechanical Coupling Time for Estimation of Heart Failure in Patients With Hypertrophic Cardiomyopathy.
    Hu S; Mi L; Fu J; Ma W; Ni J; Zhang Z; Li B; Guan G; Wang J; Zhao N
    Front Cardiovasc Med; 2022; 9():895035. PubMed ID: 35800170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.